Translational Genomics enhances human health by applying genetic research to clinical practice, improving therapies, refining risk assessments, and aiding decision-making. In musculoskeletal health, our group studies biomarkers to prevent or delay conditions like osteoporosis, sarcopenia, and frailty, promoting healthy aging and sustainable health trajectories.